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What is this project about? 
This is a Public Health project. The recent increase of 
anti-retroviral treatment (ART) in public clinics in 
South Africa means that many more people have 
access to treatment. If patients become resistant to 
the standard ART package they are put on an 
alternative second-line ART; if that fails, there is no 
further public treatment option to control the HI 
virus. Yet, literature addressing facilitators and 
barriers to treatment adherence faced by patients 
on second-line ART is scarce. 
 
The research  
This study examined factors affecting adherence to 
second-line ART from the viewpoint of clinic staff as 
well as second-line failure patients. Both individual 
and structural barriers were considered.  Research 
was conducted at a large primary-care clinic in 
Khayelitsha, a peri-urban township in Cape Town, 
South Africa. The study was conducted in 
collaboration with MSF (Doctors without Borders) at 
their facility in Khayelitsha.  
 
What did the researcher do? 
The primary research used participants who were 
drawn from an MSF-run program to support patients 
failing second-line treatment. A qualitative research 
approach was used, combining key informant 
interviews with staff (n=11), in-depth interviews with 
patients (n=10) and a Photovoice workshop with 
patients (n=11). 
 
 
 
 
What you need to know: Life-long, daily taking of ART twice a day at the same time is needed to control the level of the 
HIvirus in the blood and to allow the immune system to recover. To achieve good clinical outcomes, 95% adherence to ART is 
necessary (i.e. missing fewer than 3 doses/month). Anything less can result in drug resistance, increased sickness and mortality. In 
South Africa no third-line treatment options are available in the public sector for patients failing their second-line regimen.  
Patients and medical staff have different views of what factors make it difficult for patients to adhere to ART. Open 
communication between them is crucial.  
 
  
Being on ART means taking a 
combination of medications 
twice a day every day at the 
same time – for life! 
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Want to know more? 
Research was carried out by Whitney 
Barnett, in fulfillment of a Master of 
Public Health degree at the University 
of Cape Town. This summary is based 
on her study “Barriers to adherence in 
patients failing second-line 
antiretroviral treat-ment in a township 
in South Africa: A qualitative research 
study”. The project was supervised by 
Christopher Colvin. The thesis will be 
available on the Co-op website. 
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The research findings 
A literature review was conducted to present: 1) 
rates of non-adherence, virological failure and 
resistance and 2) to present known facilitators & 
barriers faced by patients on ART, with a specific 
focus on second-line patients.  Patients on ART 
have high rates of non-adherence (32% to 67%), 
virological failure (5.2%, to 47%) and may 
develop resistance to ARVs (5.4% to 80%).  
In this study clinic staff identified drinking, non-
disclosure, not using condoms, and pill fatigue 
as barriers to adherence, whilst patients 
identified side effects, not using condoms and 
lack of understanding around medication 
timing. With respect to service delivery, staff 
identified a need for continued counseling and 
educational support following ART initiation as 
important.  Patients were concerned about 
missing medical records and poor staff attitudes 
in the broader clinic, citing improved 
patient/staff relationships and continuity of care 
within the MSF-run program as significant.  
 
Using the research 
The study offers insight to better equip 
patients for ART adherence: Not 
condomizing is frequently cited as 
contributing to ART failure; this should be 
further examined at the staff and patient 
level to ensure that messaging is not 
misleading and that patients understand 
how their behavior may affect the impact 
of the medication.  
Continued follow-up is needed to support 
patients with regards to easily altered 
behavior or miss-understood medication 
parameters (e.g. timing, missed doses, 
forgetting).  
Continuity of care and communication 
between patients and clinic staff is another 
area that may contribute to patient 
outcomes. 
 
The study was completed in October 2012. 
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